Home NDC 72606-051 Tocilizumab-anoh
Product NDC 72606-051
11-digit product format 726060051
Labeler code 72606
Product ID 72606-051_b01afa28-11e4-47f0-9b78-bdcd8ee9e99a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name tocilizumab-anoh
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler CELLTRION USA, Inc.
Application BLA761498
Marketing category BLA
Marketing start 2026-10-01
Substance TOCILIZUMAB
Active strength 162 mg/.9mL
Pharmacologic classes Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Tocilizumab-anoh
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TOCILIZUMAB 162 mg/.9mL
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72606-051-01 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4 72606-051-01 Tocilizumab-anoh 1 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 1 4 72606-051-02 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4 72606-051-02 Tocilizumab-anoh 4 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 4 4 72606-051-03 Tocilizumab-anoh 12 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 12 4 72606-051-03 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4 72606-051-04 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4 72606-051-04 Tocilizumab-anoh 1 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 1 4 72606-051-05 Tocilizumab-anoh 4 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 4 4 72606-051-05 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4 72606-051-06 Tocilizumab-anoh 12 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 12 4 72606-051-06 Tocilizumab-anoh 0.9 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION, CONCENTRATE 0.9 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72606-051 TOCILIZUMAB-ANOH (TOCILIZUMAB) INJECTION, SOLUTION, CONCENTRATE [CELLTRION USA, INC.] 2 Current NDC, 12 package rows 20250302_60381a7e-d7ae-4384-925d-c19c418d1663.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join AVTOZMA TOCILIZUMAB CELLTRION USA, Inc. 581c288f-8015-40ef-a4c3-683c96db193d 2026-07-27 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761498
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761498 Avtozma tocilizumab-anoh 351(k) Interchangeable Rx 2026-09-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 72606-051-01 72606005101 1 SYRINGE, GLASS in 1 CARTON (72606-051-01) / .9 mL in 1 SYRINGE, GLASS 2026-10-01 No No Current 72606-051-02 72606005102 0.9 mL in 1 SYRINGE, GLASS 0.9 ml Historical 72606-051-03 72606005103 12 in 1 CARTON Historical 72606-051-04 72606005104 1 SYRINGE, GLASS in 1 CARTON (72606-051-04) / .9 mL in 1 SYRINGE, GLASS 2026-10-01 No No Current 72606-051-05 72606005105 4 in 1 CARTON Historical 72606-051-06 72606005106 12 in 1 CARTON Historical